Tempus Partners with Whitehawk for Biomarker Oncology Research
October 16, 2025
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine, announced a multi-year collaboration with Whitehawk Therapeutics, Inc, an oncology